about
Prevention of infections during primary immunodeficiencyMutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency: HuGE reviewA Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID).Pediatric Sweet syndrome and immunodeficiency successfully treated with intravenous immunoglobulin.Primary immunodeficiencies and susceptibility to parasitic infections.Towards a rAAV-based gene therapy for ADA-SCID: from ADA deficiency to current and future treatment strategies.Pathogenesis and treatment of gastrointestinal disease in antibody deficiency syndromes.Inflammatory bowel diseases in patients with adaptive and complement immunodeficiency disorders.Newborn screening for primary immunodeficiencies: beyond SCID and XLA.From murine to human nude/SCID: the thymus, T-cell development and the missing link.Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease.Association of thymectomy with infection following congenital heart surgery.Activation of B cells by antigens on follicular dendritic cells.Genotyping an immunodeficiency causing c.1624-11G>A ZAP70 mutation in Canadian Mennonites.Calculating the dose of subcutaneous immunoglobulin for primary immunodeficiency disease in patients switched from intravenous to subcutaneous immunoglobulin without the use of a dose-adjustment coefficient.Patient-centred screening for primary immunodeficiency: a multi-stage diagnostic protocol designed for non-immunologists.
P2860
Q27008430-DD8CB0F7-3A06-4FA1-B110-909558CC2CF4Q28239014-C1AF3787-AEAA-4267-A261-9C4F45009767Q35488784-B04AA5ED-A082-46DA-A9AB-074DC0F5A49CQ36341807-9964AE54-73DA-44BD-956D-B2E817732EECQ36624178-5A623751-F9D7-49B5-AE2B-70E1A9C4BDADQ37205966-A4ED31C3-6CD1-43A1-A151-87082CBF978CQ37441210-6974A55B-A974-46B6-96CF-3E2CA0647ED2Q37789681-6DA3ED39-2DD4-4579-9FD0-BB2A4C9DC2C3Q37974987-0BBE50B9-0DF8-44F1-BE77-3C128F03ACFDQ37999788-878D0854-B52B-41A5-85F8-F40685AF647CQ38070104-EA3D9DCB-477E-4560-843B-566DBAA72B75Q38117254-8B0028C5-6FFB-4FC7-AC77-24098048BCB2Q41112969-407C5003-6871-45F0-BF60-3C84D3A84850Q42240113-8D45B54F-C29B-478C-A56B-60E86956F368Q42771212-9526724E-82BE-4F02-A775-428FBC1CCE19Q51936361-947F6C4E-E277-4031-BAF7-3490D0F905A5
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Primary cellular immunodeficiencies.
@ast
Primary cellular immunodeficiencies.
@en
Primary cellular immunodeficiencies.
@nl
type
label
Primary cellular immunodeficiencies.
@ast
Primary cellular immunodeficiencies.
@en
Primary cellular immunodeficiencies.
@nl
prefLabel
Primary cellular immunodeficiencies.
@ast
Primary cellular immunodeficiencies.
@en
Primary cellular immunodeficiencies.
@nl
P356
P1476
Primary cellular immunodeficiencies.
@en
P2093
Rebecca H Buckley
P304
P356
10.1067/MAI.2002.123617
P407
P577
2002-05-01T00:00:00Z